Triazol-1-yl Benzamides Promote Anticoagulant Activity via Inhibition of Factor XIIa

化学 激肽释放酶 丝氨酸蛋白酶 凝血酶 蛋白酵素 苯甲酰胺 丝氨酸 部分凝血活酶时间 因子十二 药理学 生物化学 凝结 蛋白酶 立体化学 酶 内科学 医学 血小板
作者
Rami A. Al‐Horani,Daniel K. Afosah,Madhusoodanan Mottamal
出处
期刊:Cardiovascular and Hematological Agents in Medicinal Chemistry [Bentham Science Publishers]
卷期号:21 (2): 108-119
标识
DOI:10.2174/1871525721666221031141323
摘要

Human factor XIIa (FXIIa) is a plasma serine protease that plays a significant role in several physiological and pathological processes. Animal models have revealed an important contribution of FXIIa to thromboembolic diseases. Remarkably, animals and patients with FXII deficiency appear to have normal hemostasis. Thus, FXIIa inhibition may serve as a promising therapeutic strategy to attain safer and more effective anticoagulation. Very few small molecule inhibitors of FXIIa have been reported. We synthesized and investigated a focused library of triazol-1-yl benzamide derivatives for FXIIa inhibition.We chemically synthesized, characterized, and investigated a focused library of triazol- 1-yl benzamide derivatives for FXIIa inhibition. Using a standardized chromogenic substrate hydrolysis assay, the derivatives were evaluated for inhibiting human FXIIa. Their selectivity over other clotting factors was also evaluated using the corresponding substrate hydrolysis assays. The best inhibitor affinity to FXIIa was also determined using fluorescence spectroscopy. Effects on the clotting times (prothrombin time (PT) and activated partial thromboplastin time (APTT)) of human plasma were also studied.We identified a specific derivative (1) as the most potent inhibitor in this series. The inhibitor exhibited nanomolar binding affinity to FXIIa. It also exhibited significant selectivity against several serine proteases. It also selectively doubled the activated partial thromboplastin time of human plasma.Overall, this work puts forward inhibitor 1 as a potent and selective inhibitor of FXIIa for further development as an anticoagulant.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
NexusExplorer的应助被lkh采纳,获得10
刚刚
ws123发布了新的文献求助10
1秒前
秀丽人杰完成签到,获得积分10
2秒前
dididi发布了新的文献求助10
2秒前
王添赟发布了新的文献求助10
2秒前
汉堡包的应助被Wdw2236采纳,获得10
2秒前
乐观碧彤完成签到,获得积分10
3秒前
molihuakai的应助被不是老羊采纳,获得10
3秒前
4秒前
4秒前
4秒前
秀丽人杰发布了新的文献求助10
4秒前
4秒前
小二郎的应助被复杂的海冬采纳,获得10
4秒前
tudouning完成签到,获得积分10
4秒前
5秒前
11的应助被研友_8Y26PL采纳,获得30
5秒前
可可布朗尼完成签到,获得积分10
5秒前
5秒前
5秒前
ttchen的应助被李麟采纳,获得10
6秒前
磕磕发布了新的文献求助10
6秒前
6秒前
7秒前
zhangyupei的应助被跳跃的南琴采纳,获得10
8秒前
可若好烦完成签到,获得积分10
8秒前
orixero的应助被zyux采纳,获得10
8秒前
三文鱼发布了新的文献求助10
9秒前
zz发布了新的文献求助10
9秒前
科目三的应助被Vivian采纳,获得10
9秒前
9秒前
Ava的应助被活泼啤酒采纳,获得10
10秒前
10秒前
xinxin发布了新的文献求助10
11秒前
刘璐完成签到 ,获得积分10
11秒前
Wdw2236发布了新的文献求助10
11秒前
搜集达人的应助被研友_LNVX1L采纳,获得10
11秒前
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188088
求助须知:如何正确求助?哪些是违规求助? 9575942
关于积分的说明 21844291
捐赠科研通 7785857
什么是DOI,文献DOI怎么找? 3435158
关于科研通互助平台的介绍 2559529
邀请新用户注册赠送积分活动 2482065